Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 0 | 0 | 0 | 0 | 2,073 |
| Gross Profit | N/A | N/A | N/A | N/A | 2,073 |
| Operating Expenses | 50,693 | 50,589 | 114,276 | 18,815 | 25,361 |
| Operating Income | -50,693 | -50,589 | -114,276 | -18,815 | -23,288 |
| Interest Expense | 3,704 | 577 | 491 | 216 | 514 |
| Other Income | 3,339 | 1,969 | 5 | 14 | 472 |
| Pre-tax Income | -51,058 | -49,197 | -114,762 | -19,017 | -23,330 |
| Net Income Continuous | -51,058 | -49,197 | -114,762 | -19,017 | -23,330 |
| Net Income | $-51,058 | $-49,197 | $-114,762 | $-19,017 | $-23,330 |
| EPS Basic Total Ops | -1.32 | -1.30 | -3.60 | -58.56 | -9.38 |
| EPS Basic Continuous Ops | -1.32 | -1.30 | -3.60 | -58.51 | -9.37 |
| EPS Diluted Total Ops | -1.32 | -1.30 | -3.60 | -58.56 | -9.38 |
| EPS Diluted Continuous Ops | -1.32 | -1.30 | -3.60 | -58.51 | -9.37 |
| EPS Diluted Before Non-Recurring Items | -1.32 | -1.30 | 2.00 | N/A | -9.45 |
| EBITDA(a) | $-52,255 | $-51,005 | $-114,098 | $-18,783 | $-23,242 |